Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
Business Of Biotech
00:00
The Purpose of Biopharma Startup Leadership
The company is listed on the NASDAQ here in the US, but you're operating entirely from from Europe with 100% US investors. Is that strategic? Was that a line that way purposefully? Why you're when and why no European investors? Yes. You're not gonna piss off any European VCs with your response to this question, are you? No, probably not more than, than I have already by answering other questions. But I think there is an element of purposefulness in the way we're designed.
Transcript
Play full episode
